Star Combo Pharma Limited (S66.AX)
- Previous Close
0.1450 - Open
0.1450 - Bid 0.1350 x --
- Ask 0.1650 x --
- Day's Range
0.1450 - 0.1450 - 52 Week Range
0.1050 - 0.1875 - Volume
3,500 - Avg. Volume
2,887 - Market Cap (intraday)
19.587M - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
14.50 - EPS (TTM)
0.0100 - Earnings Date Feb 26, 2025
- Forward Dividend & Yield 0.00 (2.55%)
- Ex-Dividend Date Oct 14, 2024
- 1y Target Est
--
Star Combo Pharma Limited engages in the manufacturing and distribution of health food products and nutritional supplements in Australia and China. It operates in two segments, OEM Division and Austoyou Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is headquartered in Smithfield, Australia.
www.starcombo.com.au--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: S66.AX
View MorePerformance Overview: S66.AX
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: S66.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: S66.AX
View MoreValuation Measures
Market Cap
19.59M
Enterprise Value
10.57M
Trailing P/E
21.97
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.66
Price/Book (mrq)
0.58
Enterprise Value/Revenue
0.36
Enterprise Value/EBITDA
3.55
Financial Highlights
Profitability and Income Statement
Profit Margin
3.04%
Return on Assets (ttm)
1.26%
Return on Equity (ttm)
2.67%
Revenue (ttm)
29.56M
Net Income Avi to Common (ttm)
897.97k
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
12.95M
Total Debt/Equity (mrq)
11.65%
Levered Free Cash Flow (ttm)
3.62M